Skin and Soft Tissue Infection Flashcards

1
Q

classification of SSTI by layers of skin

A

epidermis - impetigo
dermis - ecthyma & erysipelas
hair follicles: furuncles & carbuncles
subcutaneous fat and deep dermis: cellulitis
fascia: necrotizing fascilitis
muscle: myositis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

clinical presentation of impetigo

A

localised superficial infection characterised by pustules or vesicles which then ruptured to form crusts or bullae on an erythematous base
located at the face & extremities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

clinical presentation of ecthyma

A

deeper variant of impetigo begins as vesicles/pustules –> evolve to become ulcers.
- pruitis is common.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

clinical presentation of erysipelas

A

superficial infection of the upper dermis involving the lymphatics. characterised by tender erythematous plaque with well-demarcated borders
common on face & lower extremities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

clinical presentation of furuncles & carbuncles

A

infection of hair follicles with associated small subcutaneous abscess
carbuncle: a cluster of furuncles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

clinical presentation of cellulitis

A

acute infection involving deep dermis and subcutaneous fat
- almost unilateral
- common on lower extremities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

mimickers of cellulitis:

A

deep venous thrombosis, calciphylaxis, stasis dermatitis, hematoma, erythema migrans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

the function of the skin

A

act as physical, chemical and immunological barriers against infection
- chemical: maintain acidic environment to keep microbial load low & regulate desquamation to keep transient bacteria low & sebaceous secretion inhibit growth of bacteria and fungi
- immunological: part of innate immunity & produce anti-microbial peptides to kill pathogens & normal skin commensal prevents colonisation and overgrowth of more pathogenic strains

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

pathophysiology of SSTI

A

majority results from the disruption of normal host defences –> lead to overgrowth and invasion of pathogenic micro-organisms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

risk factors of SSTI

A
  1. disruption of the skin barrier via
    - traumatic & non-traumatic
    - reduced venous & lymphatic drainage due to obesity, saphenous venectomy, chronic venous insufficiency
    - peripheral artery disease
    - age
    - physical environment (pH, soap and detergent use, humidity & moisture)
  2. medical conditions: (DM, cirrhosis, neutropenia, HIV)
    3 drugs: immunosuppressive agents & SGLT2i
  3. history of cellulitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

prevention of SSTI:

A
  • good care to maintain skin integrity
  • identity and treat predisposing factors at the time of initial diagnosis to decrease the risk of occurrence
  • acute traumatic wounds should be copiously irrigated & remove foreign objects & debride devitalised tissue
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

when culture is needed for SSTI?

A

mild and superficial infections no need (eg. impetigo, ecthyma)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What can lead to disruption of the skin barrier

A
  • traumatic injury
  • non-traumatic
  • reduced venous and lymphatic drainage
  • peripheral artery disease
  • advanced age
  • physical environment (eg. pH, soap, detergent, moisture, urine, feces, sweat, chronic wound fluid)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what are some conditions can lead to a reduced venous & lymphatic drainage

A

saphenous venectomy, obesity, chronic venous insufficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

conditions predispose to SSTI

A

diabetes, cirrhosis, neutropenia, HIV, history of cellulitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

drugs predispose to SSTI

A

immunosuppressants, SGLT2i

17
Q

how should the sample be taken for culture?

A
  • from deep in the wound after the surface cleansed
    ==> bc surface may be contaminated
  • from the base of a closed abscess where bacteria grow
  • by curettage, rather than wound swab or irrigation
    ==> bc difficult to obtain representative samples from wound swabs
18
Q

what culture is needed?

A
  • cultures of pus, exudates or tissues from the wound
  • blood culture (for severe cases with marked systemic sx of infection or immunocompromised pt)
19
Q

what conditions are considered as purulent

A

furuncles, carbuncles, skin abscesses, purulent cellulitis

20
Q

clinical presentaitons of skin abscess

A

collection of pus within the dermis and deeper skin tissues. manifest as painful, tender fluctuant and erythematous nodules

21
Q

complications of cellulitis

A

more common in immunocompromised patients
- bacteremia, endocarditis, toxic shock, glomerulonephritis, lymphedema, osteomyelitis, necrotising soft-tissue infection

bc infection is usually caused by gram pos which likes to stick to heart, joint, spine & release toxins that cause accentuated response to go into sepsis & shock

22
Q

pathogens need to cover for impetigo

A

staphylococci or streptococci, MSSA
toxin producing strain of S.aureus cause bullous

23
Q

pathogens need to cover for ecthyma

A

group A streptococcus (S.pyogenes), MSSA

24
Q

coverage for non-purulent cellulitis, erysipelas

A

mainly beta-hemolytic streptococcus (S.pyogenes), MSSA cover for moderate
Water exposure: aeromonas, vibrio vulnificus, pseudomonas aeruginosa

25
coverage for purulent infection
- mainly S.aureus. - some beta-hemolytic strep - gram-neg & anaerobe (common in patients with skin abscess involving perioral, perirectal or vulvovaginal areas) - HA-MRSA (depends on the risk factors)
26
definition for HA-MRSA
infection occurs >48 hours after hospitalisation OR outside of hospital within 12 months of exposure to healthcare
27
empiric treatment for impetigo ecthyma with multiple lesions
PO cephalexin or cloxacillin PO clindamycin if penicillin allergy duration for 7 days (severe:10-14 days)
28
culture-directed (S.pyogenes) treatment for impetigo & ecthyma
PO penicillin V and amoxicillin
29
culture-directed (MSSA) treatment for impetigo & ecthyma
PO cephalexin or cloxacillin
30
treatment for mild impetigo
often self-limiting. can give topical mupirocin BD x 5d or tropical tetracycline
31